Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedAdded a PubMed citation for Upadacitinib in moderate-to-severe atopic dermatitis (Am J Clin Dermatol, 2025) and removed the 'Online ahead of print' designation from the citation.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. This is a minor update related to documentation/versioning and does not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe PubMed publications note was updated to say publications are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check29 days agoChange DetectedThe government funding lapse notice banner was removed. The page now presents the study details without that disclaimer.SummaryDifference0.1%

- Check43 days agoChange DetectedThe update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)' on the page.SummaryDifference0.2%

- Check50 days agoChange DetectedStudy status updated from Active, not recruiting to Completed, with the completion date shown as an actual date. The last update timestamp is now displayed as an actual date rather than an estimated one.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.